title: Sulfadiazine-induced crystal nephropathy: a new 'old' problem.
authors.affiliation: Department of Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
authors.forename: Helen
authors.initials: H
authors.lastname: Slade
authors.affiliation: Department of Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
authors.forename: Eoin
authors.initials: E
authors.lastname: Mulroy
authors.affiliation: Department of Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
authors.forename: James
authors.initials: J
authors.lastname: Ussher
authors.affiliation: Department of Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
authors.forename: Tracey
authors.initials: T
authors.lastname: Putt
authors.affiliation: Department of Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
authors.forename: John
authors.initials: J
authors.lastname: Schollum
authors.affiliation: Department of Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
authors.forename: Robert
authors.initials: R
authors.lastname: Walker
mesh_terms: D000981:Antiprotozoal Agents / Q000009:adverse effects*; D003460:Crystallization; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D013411:Sulfadiazine / Q000009:adverse effects*; D014126:Toxoplasmosis, Ocular / Q000188:drug therapy
chemical_list: D000981:Antiprotozoal Agents; D013411:Sulfadiazine